ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Clindamycin Palmitate Hydrochloride Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-02-27 · last update 2026-03-26

Manufacturers: Amneal Pharmaceuticals

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)Amneal PharmaceuticalsTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 02/27/2026
Updated 02/27/2026
Discontinued 02/27/2026
Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)Amneal PharmaceuticalsTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 03/26/2026
Updated 03/26/2026
Discontinued 03/26/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)